Short Interest in Integrated BioPharma, Inc. (OTCMKTS:INBP) Increases By 1,500.0%

Integrated BioPharma, Inc. (OTCMKTS:INBP) was the recipient of a large increase in short interest during the month of March. As of March 15th, there was short interest totalling 4,800 shares, an increase of 1,500.0% from the February 28th total of 300 shares. Based on an average trading volume of 16,900 shares, the short-interest ratio is presently 0.3 days. Currently, 0.0% of the company’s shares are short sold.

Integrated BioPharma Stock Performance

Shares of OTCMKTS:INBP opened at $0.34 on Friday. Integrated BioPharma has a 12 month low of $0.16 and a 12 month high of $0.42. The company has a market capitalization of $10.30 million, a price-to-earnings ratio of 11.34 and a beta of 0.89. The firm’s 50-day moving average is $0.33 and its 200 day moving average is $0.31.

About Integrated BioPharma

Integrated BioPharma, Inc, together with its subsidiaries, manufactures, distributes, markets, and sells vitamins, nutritional supplements, and herbal products primarily in the United States and Luxembourg. It operates through Contract Manufacturing and Other Nutraceutical Businesses segments. The Contract Manufacturing segment manufactures vitamins and nutritional supplements for sale to distributors, multilevel marketers, and specialized health-care providers.